PharmTech LCGC Sciex Webinar 11.10
|Articles|July 8, 2008

LCGC to Host PharmSep Symposium

LCGC North America, the leading information provider and most trusted source among chromatographers, has announced PharmSep, a Premiere Symposium for Separation Scientists in Pharmaceuticals.

LCGC North America, the leading information provider and most trusted source among chromatographers, has announced PharmSep, a Premiere Symposium for Separation Scientists in Pharmaceuticals. PharmSep will be held from September 9-11, 2008, at the Pennsylvania Convention Center in Philadelphia, PA, and has been specially designed for separation scientists working in pharmaceutical environments. This three-day forum will showcase leading industry separation scientists teaching proven techniques for improving performance and productivity via fast separations and other advanced chromatographic techniques.

Participants will learn how to perform faster and more productive separations by interacting with leading chromatography experts from Agilent Technologies; AstraZeneca; Baxter Healthcare Corporation; Boehringer-Ingelheim Pharmaceuticals, Inc.; Cordis, a Johnson & Johnson Company; Eli Lilly and Company Inc.; Genzyme Corporation; Infinity Pharmaceuticals, Inc.; Northeasten University; Pfizer, Inc.; Schering-Plough Research Institute; S-Matrix Corporation; Synomics Pharma; USP; Waters Corporation; and many more.

For more information on this conference, please visit www.lcgcevent.com or contact Customer Service at 888-736-8547 (U.S. only) or 781-939-2588.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.